Anil Bioplus Profile
Key Indicators
- Authorised Capital ₹ 35.00 Cr
as on 11-07-2024
- Paid Up Capital ₹ 35.00 Cr
as on 11-07-2024
- Company Age 31 Year, 4 Months
- Last Filing with ROC 31 Mar 2015
- Open Charges ₹ 322.12 Cr
as on 11-07-2024
- Satisfied Charges ₹ 49.41 Cr
as on 11-07-2024
- Revenue 19.37%
(FY 2015)
- Profit -48.64%
(FY 2015)
- Ebitda 10.72%
(FY 2015)
- Net Worth 25.68%
(FY 2015)
- Total Assets 18.52%
(FY 2015)
About Anil Bioplus
The Corporate was formerly known as Anil Biochem Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2015. It's a company limited by shares with an authorized capital of Rs 35.00 Cr and a paid-up capital of Rs 35.00 Cr.
The company currently has active open charges totaling ₹322.12 Cr. The company has closed loans amounting to ₹49.41 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashish Shah, Vishad Jagasheth, and Amol Sheth serve as directors at the Company.
- CIN/LLPIN
U51909GJ1993PLC019894
- Company No.
019894
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 Jul 1993
- Date of AGM
30 Sep 2015
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Anil Bioplus Limited offer?
Anil Bioplus Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Dyeing Auxiliaries, Sodium Gluconate.
Who are the key members and board of directors at Anil Bioplus?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ashish Shah | Additional Director | Current | |
Vishad Jagasheth | Additional Director | Current | |
Amol Sheth | Director | 16-Jan-1995 | Current |
Financial Performance and Corporate Structure Insights of Anil Bioplus.
Anil Bioplus Limited, for the financial year ended 2015, experienced significant growth in revenue, with a 19.37% increase. The company also saw a substantial fall in profitability, with a 48.64% decrease in profit. The company's net worth Soared by an impressive increase of 25.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Anil Bioplus?
In 2015, Anil Bioplus had a promoter holding of 98.70% and a public holding of 1.30%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 10 Nov 2015 | ₹10.00 Cr | Open |
Bank Of India Creation Date: 27 Feb 2013 | ₹95.00 Cr | Open |
Bank Of India Creation Date: 11 Aug 2012 | ₹95.00 Cr | Open |
How Many Employees Work at Anil Bioplus?
Anil Bioplus has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anil Bioplus, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anil Bioplus's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.